These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32662625)

  • 1. Hollow Mesoporous Silica Nanoparticles with Extra-Large Mesopores for Enhanced Cancer Vaccine.
    Lee JY; Kim MK; Nguyen TL; Kim J
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34658-34666. PubMed ID: 32662625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylenimine Hybrid Thin-Shell Hollow Mesoporous Silica Nanoparticles as Vaccine Self-Adjuvants for Cancer Immunotherapy.
    Liu Q; Zhou Y; Li M; Zhao L; Ren J; Li D; Tan Z; Wang K; Li H; Hussain M; Zhang L; Shen G; Zhu J; Tao J
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47798-47809. PubMed ID: 31773941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy.
    Nguyen TL; Choi Y; Kim J
    Adv Mater; 2019 Aug; 31(34):e1803953. PubMed ID: 30417454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable dual-scale mesoporous silica cancer vaccine enabling efficient delivery of antigen/adjuvant-loaded nanoparticles to dendritic cells recruited in local macroporous scaffold.
    Nguyen TL; Cha BG; Choi Y; Im J; Kim J
    Biomaterials; 2020 May; 239():119859. PubMed ID: 32070828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of antigen-specific immunity by mesoporous silica nanoparticles incorporating antigen peptides.
    Goto K; Ueno T; Sakaue S
    J Biosci Bioeng; 2024 Sep; 138(3):254-260. PubMed ID: 38890051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy.
    Lu Y; Yang Y; Gu Z; Zhang J; Song H; Xiang G; Yu C
    Biomaterials; 2018 Aug; 175():82-92. PubMed ID: 29803106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra-Large Pore Mesoporous Silica Nanoparticles Enabling Co-Delivery of High Amounts of Protein Antigen and Toll-like Receptor 9 Agonist for Enhanced Cancer Vaccine Efficacy.
    Cha BG; Jeong JH; Kim J
    ACS Cent Sci; 2018 Apr; 4(4):484-492. PubMed ID: 29721531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extra-Large Pore Mesoporous Silica Nanoparticles for Directing in Vivo M2 Macrophage Polarization by Delivering IL-4.
    Kwon D; Cha BG; Cho Y; Min J; Park EB; Kang SJ; Kim J
    Nano Lett; 2017 May; 17(5):2747-2756. PubMed ID: 28422506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
    Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
    Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
    Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
    ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of mesoporous hollow silica nanospheres using polymeric micelles as template and their application as a drug-delivery carrier.
    Sasidharan M; Zenibana H; Nandi M; Bhaumik A; Nakashima K
    Dalton Trans; 2013 Oct; 42(37):13381-9. PubMed ID: 23887599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
    Mody KT; Popat A; Mahony D; Cavallaro AS; Yu C; Mitter N
    Nanoscale; 2013 Jun; 5(12):5167-79. PubMed ID: 23657437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid mesoporous silica nanospheres modified by poly (NIPAM-co-AA) for drug delivery.
    Zhang K; Zhou D; Wang Z; Zhang Y; He P
    Nanotechnology; 2019 Aug; 30(35):355604. PubMed ID: 31071691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hollow Structure Improved Anti-Cancer Immunity of Mesoporous Silica Nanospheres In Vivo.
    Wang X; Li X; Ito A; Yoshiyuki K; Sogo Y; Watanabe Y; Yamazaki A; Ohno T; Tsuji NM
    Small; 2016 Jul; 12(26):3510-5. PubMed ID: 27191183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Pore Mesoporous-Silica-Coated Upconversion Nanoparticles as Multifunctional Immunoadjuvants with Ultrahigh Photosensitizer and Antigen Loading Efficiency for Improved Cancer Photodynamic Immunotherapy.
    Ding B; Shao S; Yu C; Teng B; Wang M; Cheng Z; Wong KL; Ma P; Lin J
    Adv Mater; 2018 Dec; 30(52):e1802479. PubMed ID: 30387197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice.
    Wagner J; Gößl D; Ustyanovska N; Xiong M; Hauser D; Zhuzhgova O; Hočevar S; Taskoparan B; Poller L; Datz S; Engelke H; Daali Y; Bein T; Bourquin C
    ACS Nano; 2021 Mar; 15(3):4450-4466. PubMed ID: 33648336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic virus-like mesoporous silica nanoparticles improved cellular internalization for co-delivery of antigen and agonist to enhance Tumor immunotherapy.
    Gao Y; Zhang Y; Xia H; Ren Y; Zhang H; Huang S; Li M; Wang Y; Li H; Liu H
    Drug Deliv; 2023 Dec; 30(1):2183814. PubMed ID: 36843529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silica nanorattle with enhanced protein loading: a potential vaccine adjuvant.
    Liu T; Liu H; Fu C; Li L; Chen D; Zhang Y; Tang F
    J Colloid Interface Sci; 2013 Jun; 400():168-74. PubMed ID: 23582904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.